Patents by Inventor Lee Schroeder

Lee Schroeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210406731
    Abstract: A network-implemented integrated modeling system for genetic risk estimation uses guideline factor information and other input information to determine models usable for estimating genetic risk of disease in patients. Models are determined using established network connections with external sources. Health history information is collected from a patient, which is then processed against a relevant model to estimate the genetic risk of a disease corresponding to that model in that patient. Based on results of the estimation, a pedigree chart representing personal and family risk for the patient is generated and output to the patient and/or health care representatives of the patient. The results may be disseminated to one or more distributed computing environments from a central server which performs the genetic risk estimation. In some cases, follow-up validations performed using further collected data are used to update the constraints used to determine the models.
    Type: Application
    Filed: December 30, 2020
    Publication date: December 30, 2021
    Applicant: InheRET, INC.
    Inventors: David Keren, Sofia Merajver, Lynn McCain, Amanda Cook, Lee Schroeder, Kara Milliron
  • Publication number: 20070299331
    Abstract: Ultrashort laser pulses are used to induce photodisruptive breakdown in vasculature in an animal to controllably produce hemorrhage, thrombosis or breach of blood-brain barrier in individual, specifically targeted blood vessels. Damage is limited to the targeted vessels such that neighboring vessels exhibit no signs of vascular damage, including vessels directly above or below the targeted vessel. Ultrashort laser pulses of lower energy are also used to observe and quantify the baseline and altered states of blood flow. Observation and measurement may be performed (1) by TPLSM, OCT or other known techniques, providing a real-time, in vivo model for the dynamics and effects of vascular injury.
    Type: Application
    Filed: July 13, 2007
    Publication date: December 27, 2007
    Inventors: Beth FRIEDMAN, David KLEINFELD, Patrick LYDEN, Nozomi NISHIMURA, Christopher SCHAFFER, Lee SCHROEDER, Philbert TSAI
  • Publication number: 20060142746
    Abstract: Ultrashort laser pulses are used to induce photodisruptive breakdown in vasculature in an animal to controllably produce hemorrhage, thrombosis or breach of the blood-brain barrier in individual, specifically-targeted blood vessels. Damage is limited to the targeted vessels such that neighboring vessels exhibit no signs of vascular damage, including vessels directly above and directly below the targeted vessel. Ultrashort laser pulses of lower energy are also used to observe and quantify the baseline and altered states of blood flow. Observation and measurement may be performed by TPLSM, OCT or other known techniques, providing a real-time, in vivo model for the dynamics and effects of vascular injury.
    Type: Application
    Filed: December 11, 2003
    Publication date: June 29, 2006
    Inventors: Beth Friedman, David Kleinfeld, Patrick Lyden, Nozomi Nishimura, Christopher Schaffer, Lee Schroeder, Philbert Tsai